Press "Enter" to skip to content

Tag: Canada

Most Quebeckers lose flu shot coverage as viral season gets early start

Quebeckers who are not considered high-risk will have to pay nearly $200 to get vaccinated against influenza and COVID-19 this season, charting a path opposite to other provinces in Canada as the viral season picks up speed.

Quebec is the only province scrapping universal flu coverage, owing its decision to guidance from the province’s immunization committee. Only some categories will be eligible for a free flu shot, such as Quebeckers 65 and older; people with certain chronic conditions – such as immunocompromised people – and those living with them; pregnant women; residents of seniors’ homes and long-term care facilities.

Those who do not qualify can expect to be charged around $150 for the COVID-19 vaccine, which came into effect in the province last year. Now, they will also need to pay between $30 and $40 for the flu shot, said Marilie Beaulieu-Gravel, a spokesperson for the association representing pharmacy owners in Quebec.

Comments closed

Flu and COVID-19 vaccines available to some Ontarians starting today. Here is who is eligible

The Ontario government is launching its fall immunization program ahead of flu season and some people can get their shots starting this week.

In a news release, the Ministry of Health said an initial supply of COVID-19 and flu vaccines will be available for high-risk and priority groups who live, work or study in Ontario starting Monday. Those individuals include:

  • Hospitalized patients
  • Hospital staff
  • Residents and staff in long-term care homes, retirement homes and other congregate settings
  • Individuals aged 65 and older
Comments closed

‘Outdated’ health policies surrounding Covid still pose a danger today, says U of C researcher

University of Calgary professor Mark Ungrin has dedicated years of research highlighting what he believes is of significant concern to all Canadians’ health.

He says health policy and the federal government’s response to Covid was based on outdated information, and even today that same policy remains in place.

“Unfortunately, when Covid hit, there was very little attention paid to aerosol transmission as a means of Covid infecting from one person to another,” Ungrin said. “Warnings were provided by scientists, engineers, occupational health and safety experts, many people within the medical profession, but infection control leaders really based their decisions on some fairly outdated understandings of aerosol biology and disease transmission via aerosols, and as a result, they basically assumed that it was not possible for Covid to be airborne.”

Comments closed

Health Canada Authorizes Pfizer and BioNTech’s Omicron XFG-Adapted COVID-19 Vaccine

KIRKLAND, QC, Sept. 17, 2026 /CNW/ — Pfizer Canada ULC and BioNTech SE today announced that Health Canada has authorized the XFG variant-adapted COMIRNATY® for active immunization of individuals aged 6 months and older against COVID-19. The updated COMIRNATY® vaccine targets the Omicron XFG lineage, in alignment with public health recommendations for the 2026-2027 season.

The Health Canada approval is based on the cumulative body of evidence previously submitted by Pfizer and BioNTech that includes clinical, non-clinical and real-world data supporting the safety and effectiveness of COMIRNATY®.

Comments closed

Alberta government maintaining COVID vaccine fee as it prepares for fall influenza campaign

Province says Albertans can start booking vaccination appointments on Oct. 5

The Alberta government says its provincewide influenza, COVID and respiratory syncytial virus vaccination campaign will begin next month.

In a news release issued Monday, the province said it’s maintaining the $100 fee it brought in last year for those seeking the COVID vaccine, though there’s a long list of reasons that could see the fee be waived for people, such as having health conditions that put them at risk for severe illness.

Comments closed

Provinces are turning to U.S. health-care workers to help with shortages. And it’s working

Recruitment can help fill gaps, but experts say Canada needs to do more to retain its own health-care workers

Registered nurse Shane Tyson was done with the U.S.

He was working in Minnesota at the not-for-profit Mayo Clinic Health System and the Olmsted Medical Center. But in 2025, Tyson says he became increasingly concerned about the deterioration of health care, as well as tighter immigration enforcement.

Then ICE agents arrested a patient as they were leaving a primary care appointment where he worked, Tyson says.

Comments closed

Free N95 masks available in many BC Interior communities as smoke persists

While there has been bits of relief at times over the past few days, wildfire smoke continues to be a part of our daily lives in the BC Interior right now.

Of course, wildfire smoke exposure can affect both short-term and long-term health, and people can’t always stay inside to avoid the poor outdoor air quality.

As a result, the Canadian Red Cross has stepped up to offer free N95 respirator masks across many BC Interior communities.

Comments closed

City of Castlegar offering free N95 masks

As wildfires continue to impact air quality across the West Kootenay, the City of Castlegar is offering free N95 masks through several local facilities and organizations.

Short-term smoke exposure can cause headaches, irritated eyes, sore throat, coughing, wheezing and worsen existing heart and lung conditions. In the long term, smoke exposure can contribute to the development of chronic diseases, such as heart disease and dementia, according to the Province of B.C. who has declared a provincial state of emergency due to the numerous wildfires throughout the province.

The province advises the best way to reduce health risks from wildfire smoke is to reduce exposure – create a clean air space at home, avoid strenuous exercise, avoid outdoor activities and wear a well-fitted N95 mask.

Comments closed

‘I couldn’t breathe’: the deadly health burden of wildfire smoke

Scientists race to untangle complex links between exposure and mortality as fire weather grows more prevalent

A thousand kilometres from the infernos gorging on northern Ontario’s boreal forests, Erin O’Connor watched the sky above Canada’s biggest city turn an “almost post-apocalyptic” orange as it filled with light-scattering particles of soot and ash. Stepping outside the halls of Toronto General hospital, where air filters were keeping patients safe from the worst of the fumes, she was struck by a smell so strong it felt like standing by a campfire.

“It really hit you in the face as soon as you walked outside,” said O’Connor, who runs University Health Network’s emergency department and saw a rise in patients presenting with allergies and shortness of breath. “As the days progressed, it was like that everywhere. It seemed even inside you could smell that burning.”

Far more than the flames that have engulfed southern Europe and North America in recent weeks, it is the smoke that dominates the astonishing death toll from combusting nature. Thick with toxic gases that inflame the airways and tiny particulates that breach the lungs and ride the bloodstream to hit every organ in the body, fumes from landscape fires kill 1.5 million people each year, a study in the Lancet found in 2024 – more than floods, flames, storms and heat combined.

Comments closed

Ticks have become a permanent fixture in Montreal’s parks

Ticks can transmit Lyme disease, among other things, as well as other bacteria.

Montrealers must now share their picnics and walks with some new parasitic neighbours: ticks. It is a presence that even the most city-bound residents will have to get used to, as these ticks are not about to go away any time soon, according to ecologists.

“We can’t get rid of them; it’s inevitable,” Jacques Brodeur, an ecologist and researcher at the University of Montreal, states bluntly. Ticks have arrived in Montreal, and it will not be possible to dislodge them, he believes.

Gone are the days when these ticks were mainly found in the tall grass of the Montérégie region. The tiny creatures are now everywhere, from the Outaouais to the Chaudière-Appalaches region, including major urban centres. Particularly in less well-maintained parks, Mr. Brodeur points out.

Comments closed

Metro Vancouver issues air quality warning

Hot temperatures and wildfire smoke have prompted a yellow air quality warning from Metro Vancouver.

The regional district issued the warning Thursday afternoon for residents of the east side of Metro Vancouver and the Fraser Valley. Environment Canada has also issued a heat warning for much of the province.

The Brunswick Complex of wildfires near Boston Bar, as well as wildfires in the southern Interior, are being blamed for an increase in smog and fine particulate matter concentrations.

Comments closed

COVID-19 outbreak declared over at Trail hospital

A COVID-19 outbreak on the second-floor surgical unit at Kootenay Boundary Regional Hospital in Trail has been declared over.

Interior Health said the outbreak ended Wednesday, July 15, after 12 patient cases were associated with the outbreak.

The causative agent was identified as COVID-19.

The outbreak was declared July 6 after the first case was identified July 1.

Comments closed

New Study Provides First Evidence of Dopamine System Injury in the Brain of Long COVID Patients

Findings have important implications for the pathophysiology of key COVID symptoms and suggest new potential avenues for treatment

Toronto, ON (July 10, 2026) — A new brain imaging study led by researchers at the Centre for Addiction and Mental Health (CAMH), published in eBioMedicine, provides the strongest evidence to date that long COVID is associated with injury to dopamine-releasing neurons in the brain—a finding that may explain symptoms such as lack of motivation due to fatigue, slowed movement, and memory difficulties, and could open the door to new treatment strategies.

Long COVID is estimated to affect five per cent of the world population, including two million Canadians, and is characterized by a wide range of persistent and sometimes debilitating symptoms, including brain-related ones such as fatigue, brain fog, memory problems, or low mood, that continue for at least three months following the initial COVID-19 infection. Despite its prevalence, no evidence-based treatments currently exist, largely due to limited understanding of the underlying brain pathology.

In the new study, researchers used positron emission tomography (PET) brain imaging to measure a well-established marker of dopamine neuron integrity in people with long COVID and healthy individuals.

Comments closed

Quebec can no longer remain inactive

The author sounds the alarm on the risks posed by long COVID and demands that Quebec inject money to finance research and treatments

My daughter has been living with COVID for almost two years. She suffers day after day, without access to proper treatment. She endures overwhelming fatigue, brain fog, severe insomnia, trigeminal neuralgia and a disorder of the autonomic nervous system where her heart accelerates abnormally when she stands, causing dizziness, intense fatigue and faintness. She spends almost 20 hours a day in bed. Her husband has had to stop working to take care of her and their two children. I can’t stand by and watch her suffer.

This is not an isolated case: this suffering, sometimes present for six years, is still ignored by our health system, even though the existence of long COVID is firmly established by science.

Comments closed

Seasonal COVID-19 vaccination in 2025/26 reduced risk of illness by half in Canada

An interim analysis published in Eurosurveillance estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, offering protection beyond the vaccine’s target strain.

Seasonal COVID-19 vaccination is recommended in Canada as in several other countries for people older than 6 months with an increased risk of severe illness from the infection, and for all adults aged 65 or older. In the 2025/26 respiratory virus season, the vaccine was updated to target the LP.8.1 strain as recommended by the World Health Organization (WHO), but other strains were also circulating during that period.

Comments closed

1400 days with long COVID; the latest findings offering hope for a cure

Although COVID-19 is no longer a hot topic, this disease still takes a toll on thousands of people who contract the virus and develop severe long-term symptoms. A meeting was held in Québec to discuss the latest findings on long COVID.

The daughter of Sylvain Thibault and Noémie Lévesque is 17 years old. She has been living with severe symptoms of long COVID since she was 13 years old, for 1400 days. Today, this teen’s daily routine is spent in bed for half the day. “She no longer has much of a life right now,” her father laments. “Her body is holding her back.”

Comments closed

Hospitalization rates for illnesses like COVID, flu have doubled since pre-pandemic, report finds

Vaccine-preventable respiratory infections sending thousands to hospital, all while vaccine uptake is dropping

Years after the virus that causes COVID-19 kicked off a global pandemic, it’s still sending thousands of Canadians into hospital each year alongside other respiratory infections — despite a suite of vaccines that can slash someone’s risk of serious illness.

Striking new data from the Canadian Institute for Health Information (CIHI) shows hospitalization rates for vaccine-preventable respiratory diseases more than doubled in 2024 compared to pre-pandemic levels, all while vaccination rates are backsliding.

There were 142 hospitalizations for every 100,000 Canadians that year, the data shows, up from roughly 66 per 100,000 in 2019.

Comments closed

Common antidepressant can treat long COVID fatigue symptoms: study

A common and low-cost antidepressant can successfully treat fatigue associated with long COVID, according to a new study.

Co-led by researchers from McMaster University in Ontario, the study found that the drug fluvoxamine, which is commonly sold under the name Luvox, significantly reduced fatigue symptoms in a clinical trial of 399 adults with long COVID. It is one of the first times a medication has been shown to effectively treat the condition.

“This is an important step forward for patients who have been desperate for evidence‑based options,” senior author and McMaster University professor Edward Mills said in a news release.

Comments closed